28th July 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

Govt preparing to establish the Drug Tribunal Board

To legalize offences covered by the Drugs and Cosmetics Act, the government is preparing to establish a Drug Tribunal Board. Union Minister of Health and Family Welfare and Chemicals and Fertilizers made the decision to address trade margin rationalization.

Pharmaceutical companies begin conversations with Centre about developing monkeypox vaccine

With the government, several pharma companies are debating the development of a possible monkeypox vaccine. The vaccine against monkeypox is being discussed with other vaccine manufacturing companies, although any decisions are still quite tentative at this point.

Pharma companies in Himachal Pradesh opposed to trade margin caps

Distributors rather than prescription-based marketing reps cover the Tier II cities, remote areas, interior, and rural areas. Their trade margins will be capped by the proposed action.

CDSCO issues a warning on Baxter's blood purification equipment hemoperfusion cartridge

Due to the presence of particle matter within the cartridge, the Central Drugs Standard Control Organization (CDSCO) has issued a medical devices alert on Baxter Healthcare’s Absorba Hemoperfusion Cartridge 300 C and Absorba 300 C, devices used in blood purification.

Dr. Reddy's introduces the cancer medication Bortezomib in the US

The Hyderabad-based pharma company received US Food and Drug Administration certification before launching the cancer treatment product (USFDA). The company sells the Velcade brand’s generic equivalent.

World's first medical grade CardiacSense watch to monitor heart launched by Xplore Lifestyle

The most cutting-edge cardiac and other vital signs monitoring technology has been developed in partnership with an Israeli business by Xplore Lifestyle, the nation’s leading and future MedTech solutions supplier, and is now available as an easy-to-wear watch.

Regen BioPharma seeking a US patentfor their second generation survivin mRNA cancer immunotherapy vaccine

In order to increase the effectiveness of its unique survivin mRNA cancer immunotherapeutic vaccine, Regen BioPharma, has filed a provisional patent application with the United States Patent and Trademark Office (USPTO).

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.
Start chat
1
Need Help?
PharmaState Academy
Hello, how can we help you?